JP2024529527A5 - - Google Patents

Info

Publication number
JP2024529527A5
JP2024529527A5 JP2024506443A JP2024506443A JP2024529527A5 JP 2024529527 A5 JP2024529527 A5 JP 2024529527A5 JP 2024506443 A JP2024506443 A JP 2024506443A JP 2024506443 A JP2024506443 A JP 2024506443A JP 2024529527 A5 JP2024529527 A5 JP 2024529527A5
Authority
JP
Japan
Prior art keywords
group
groups
alkyl
halogenated
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024506443A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024529527A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/110017 external-priority patent/WO2023011539A1/zh
Publication of JP2024529527A publication Critical patent/JP2024529527A/ja
Publication of JP2024529527A5 publication Critical patent/JP2024529527A5/ja
Pending legal-status Critical Current

Links

JP2024506443A 2021-08-04 2022-08-03 シクロアルケン系誘導体調節剤、その製造方法及び応用 Pending JP2024529527A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
CN202110892791 2021-08-04
CN202110892791.3 2021-08-04
CN202111322097 2021-11-09
CN202111322097.4 2021-11-09
CN202210041958.X 2022-01-14
CN202210041958 2022-01-14
CN202210540040.X 2022-05-17
CN202210540040 2022-05-17
PCT/CN2022/110017 WO2023011539A1 (zh) 2021-08-04 2022-08-03 环烯类衍生物调节剂、其制备方法和应用

Publications (2)

Publication Number Publication Date
JP2024529527A JP2024529527A (ja) 2024-08-06
JP2024529527A5 true JP2024529527A5 (cg-RX-API-DMAC7.html) 2025-07-31

Family

ID=85155248

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024506443A Pending JP2024529527A (ja) 2021-08-04 2022-08-03 シクロアルケン系誘導体調節剤、その製造方法及び応用

Country Status (11)

Country Link
US (1) US20240360109A1 (cg-RX-API-DMAC7.html)
EP (1) EP4382525A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024529527A (cg-RX-API-DMAC7.html)
KR (1) KR20240042624A (cg-RX-API-DMAC7.html)
CN (1) CN117751110A (cg-RX-API-DMAC7.html)
AU (1) AU2022321506A1 (cg-RX-API-DMAC7.html)
CA (1) CA3227366A1 (cg-RX-API-DMAC7.html)
IL (1) IL310400A (cg-RX-API-DMAC7.html)
MX (1) MX2024001331A (cg-RX-API-DMAC7.html)
TW (1) TW202321227A (cg-RX-API-DMAC7.html)
WO (1) WO2023011539A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7812052B2 (ja) 2020-09-01 2026-02-09 江蘇恒瑞医薬股▲ふん▼有限公司 縮合イミダゾール誘導体、その調製方法及びその医薬的応用
SI4408840T1 (sl) 2021-09-27 2025-12-31 Terns Pharmaceuticals, Inc. Benzimidazolne karboksilne kisline kot agonisti GLP-1R
US12024507B2 (en) 2021-10-25 2024-07-02 Terns Pharmaceuticals, Inc. Compounds as GLP-1R agonists
AU2023224854A1 (en) 2022-02-23 2024-10-03 Terns Pharmaceuticals, Inc. Compounds as glp-1r agonists
KR20250139383A (ko) * 2023-02-02 2025-09-23 장쑤 한서 파마슈티칼 그룹 캄파니 리미티드 시클로알켄계 화합물의 염, 결정형 및 이의 제조 방법과 응용
PE20252787A1 (es) 2023-04-07 2025-12-22 Terns Pharmaceuticals Inc Combinacion que comprende un agonista de thr-beta y un agonista de glp-1r para su uso en el tratamiento de un trastorno hepatico o una enfermedad cardiometabolica
EP4777197A2 (en) 2023-09-14 2026-07-22 Ascletis Pharma (China) Co., Limited Glp-1r agonist and therapeutic method thereof
WO2025109387A1 (en) 2023-11-24 2025-05-30 Ascletis Pharma (China) Co., Limited Glp-1r agonist and therapeutic method thereof
WO2025247390A1 (zh) * 2024-05-31 2025-12-04 福佑泰生物制药公司 可用作glp-1r激动剂的杂双环化合物
WO2025252201A1 (zh) * 2024-06-07 2025-12-11 江苏豪森药业集团有限公司 一种环烯类衍生物的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016022742A1 (en) * 2014-08-08 2016-02-11 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
WO2018109607A1 (en) * 2016-12-16 2018-06-21 Pfizer Inc. Glp-1 receptor agonists and uses thereof
CA3045644C (en) * 2018-06-13 2024-01-16 Pfizer Inc. Glp-1 receptor agonists and uses thereof
FI3806855T3 (fi) * 2018-06-15 2023-05-04 Pfizer Glp-1 -reseptorin agonisteja ja niiden käyttöjä
EA202191432A1 (ru) * 2018-11-22 2021-10-14 Цилу Регор Терапьютикс Инк. Агонисты glp-1r и их применения
AU2020256647B2 (en) * 2019-04-12 2025-07-31 Qilu Regor Therapeutics Inc. GLP-1R agonists and uses thereof
WO2021018023A1 (zh) * 2019-08-01 2021-02-04 济南泰达领创医药技术有限公司 小分子glp-1受体调节剂
CR20220178A (es) * 2019-10-25 2022-06-15 Gilead Sciences Inc Compuestos moduladores de glp-1r
ES3029360T3 (en) * 2019-11-15 2025-06-24 Ildong Pharmaceutical Co Ltd Glp-1 receptor agonist and use thereof
WO2021219019A1 (en) * 2020-04-29 2021-11-04 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
JP2023538408A (ja) * 2020-08-21 2023-09-07 ターンズ・ファーマシューティカルズ・インコーポレイテッド Glp-1r作動薬としての化合物
JP7812052B2 (ja) * 2020-09-01 2026-02-09 江蘇恒瑞医薬股▲ふん▼有限公司 縮合イミダゾール誘導体、その調製方法及びその医薬的応用
JP2023546055A (ja) * 2020-10-13 2023-11-01 ガシャーブラム・バイオ・インコーポレイテッド ヘテロ環glp-1アゴニスト
CN114805336B (zh) * 2021-01-20 2026-04-14 江苏恒瑞医药股份有限公司 稠合咪唑类化合物、其制备方法及其在医药上的应用

Similar Documents

Publication Publication Date Title
JP2024523525A5 (cg-RX-API-DMAC7.html)
AU2019239955B2 (en) Kv7 channel activators compositions and methods of use
JP2023509422A5 (cg-RX-API-DMAC7.html)
JP2006502143A5 (cg-RX-API-DMAC7.html)
JP2021523221A5 (cg-RX-API-DMAC7.html)
JP2022510925A5 (cg-RX-API-DMAC7.html)
JP2010540508A5 (cg-RX-API-DMAC7.html)
JP2021535112A5 (cg-RX-API-DMAC7.html)
JP2011507878A5 (cg-RX-API-DMAC7.html)
JP2014508720A5 (cg-RX-API-DMAC7.html)
JP2023553428A5 (cg-RX-API-DMAC7.html)
JP2022511477A5 (cg-RX-API-DMAC7.html)
JP2024516033A5 (cg-RX-API-DMAC7.html)
JP2021522262A5 (cg-RX-API-DMAC7.html)
JP2024525368A5 (cg-RX-API-DMAC7.html)
AU2021282122B2 (en) Fluoropyrrolopyridine compound and application thereof
RU2017110211A (ru) ИНГИБИТОРЫ α-АМИНО-β-КАРБОКСИМУКОНАТ-ε-СЕМИАЛЬДЕГИД-ДЕКАРБОКСИЛАЗЫ
JP2020531454A5 (cg-RX-API-DMAC7.html)
JP2021530560A5 (cg-RX-API-DMAC7.html)
JP2024528982A5 (cg-RX-API-DMAC7.html)
JP2023544716A5 (cg-RX-API-DMAC7.html)
JP2025516719A5 (cg-RX-API-DMAC7.html)
JP2022542140A5 (cg-RX-API-DMAC7.html)
JP2024509760A5 (cg-RX-API-DMAC7.html)
RU2010136721A (ru) Агонисты мускариновых рецепторов, композиции, способы лечения ими и способы их изготовления